Ma C, et al. – This systematic review aimed to evaluate the efficacy and safety outcomes reported in ulcerative colitis (UC) placebo-controlled randomized controlled trials (RCTs). Important heterogeneity in reporting and variability in endpoint definitions remained despite recent advances in clinical trials methodology. A need existed to develop and validate a core outcome set (COS) for UC clinical trials.